[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550979":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":11,"responsibleParty":26,"collaborators":28,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":11,"eligibilityCriteria":38,"healthyVolunteers":34,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":11,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":11,"overallStatus":52,"whyStopped":11,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":11},{"fullName":5,"class":6},"Oui Therapeutics, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment","EXPERIMENTAL",null,[13],"Device: OTX-401",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","OTX-401","Evidence-based treatments for obesity and binge eating",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Brian Keenaghan","CONTACT","2037254024","brian@ouitherapeutics.com",{"type":27,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[29],{"name":30,"class":31},"National Institute of Mental Health (NIMH)","NIH","100550979","feasibility-of-a-digital-therapeutic-for-adults-with-binge-eating-and-obesity-100550979",false,"NCT06454123","Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity","A Feasibility Study of a Digital Therapeutic for Adults With Recurrent Binge Eating and Obesity","Inclusion Criteria:\n\n1. English speaking male or female patients, 18-70 years\n2. Patients with recurrent binge eating (≥12 episodes in 3 months) and obesity (BMI ≥30)\n3. Understand written and spoken English\n4. Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher\n5. Willing and able to complete enrollment procedures\n6. Able to understand the nature of the study and provide written informed consent\n\nExclusion Criteria:\n\n1. Patients with active psychosis\n2. Patients who are acutely intoxicated at the time of enrollment\n3. Currently enrolled in other treatment studies for the symptoms and behaviors targeted\n4. Patients who are cognitively impaired\n5. Patients who, in the judgment of the investigator, would have an unfavorable risk\u002Fbenefit profile with respect to the digital therapeutic","ALL","18 Years","70 Years",{"count":43,"type":44},30,"ESTIMATED","INTERVENTIONAL",[47],"NA","The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.",[50,51],"Binge Eating","Obesity","NOT_YET_RECRUITING","2024-06-06",{"date":55,"type":56},"2024-06-12","ACTUAL",{"date":58,"type":44},"2024-09",{"date":60,"type":44},"2025-06",{"name":5,"class":6}]